Deerfield Beach, FLORIDA3 Active Studies

Neuroendocrine Tumors Clinical Trials in Deerfield Beach, FLORIDA

Find 3 actively recruiting neuroendocrine tumors clinical trials in Deerfield Beach, FLORIDA. Connect with local research sites and explore new treatment options.

3
Active Trials
1
Sponsors
264
Enrolling

Recruiting Neuroendocrine Tumors Studies in Deerfield Beach

About Neuroendocrine Tumors Clinical Trials in Deerfield Beach

Neuroendocrine tumors (NETs) develop from hormone-producing cells and can occur in many organs, most commonly the gastrointestinal tract and lungs. They range from slow-growing to aggressive. Treatment includes surgery, somatostatin analogs, targeted therapy, and peptide receptor radionuclide therapy.

There are currently 3 neuroendocrine tumors clinical trials recruiting participants in Deerfield Beach, FLORIDA. These studies are seeking a combined 264 participants. Research is being sponsored by National Cancer Institute (NCI). Clinical trial participation is free and participants receive study-related medical care at no cost.

Neuroendocrine Tumors Clinical Trials in Deerfield Beach — FAQ

Are there neuroendocrine tumors clinical trials in Deerfield Beach?

Yes, there are 3 neuroendocrine tumors clinical trials currently recruiting in Deerfield Beach, FLORIDA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Deerfield Beach?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Deerfield Beach research site will contact you about next steps.

Are clinical trials in Deerfield Beach free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Deerfield Beach studies also compensate for your time and travel.

What neuroendocrine tumors treatments are being tested?

The 3 active trials in Deerfield Beach are testing new therapies including novel drugs, biologics, and treatment approaches for neuroendocrine tumors.

Data updated March 2, 2026 from ClinicalTrials.gov